Curing Death
  Recent News |  Archives |  Tags |  About |  Newsletter |  Submit News |  Advertise With Us |  Subscribe to CuringDeath.com RSS Fee Subscribe

Link unraveled between chromosomal instability and centrosome defects in cancer cells (6/9/2009)

Tags:
cancer

In a new study, Dana-Farber Cancer Institute scientists disprove a century-old theory about why cancer cells often have too many or too few chromosomes, and show that the actual reason may hold the key to a novel approach to cancer therapy.

Since the late 19th century, scientists have attributed the surplus or shortage of intact chromosomes in cancer cells to a kind of fragmentation in cell division: instead of dividing neatly into two identical daughter cells, as normal cells do, cancer cells were thought to frequently split into three or four cells, each with a motley assortment of chromosomes. This explosive division was thought to occur because many cancer cells have extra centrosomes, tiny circular structures that help pairs of chromosomes line up in preparation for cell division.

When study lead author Neil Ganem, PhD, of Dana-Farber used newly developed microscope equipment to watch living cancer cells for a week or more, he found that not only were such abnormal divisions quite rare, but the resulting daughter cells were so discombobulated by their chromosomal quirks, they generally survived for only a few days - far too briefly to deliver abnormal chromosome content to a tumor.

The way that extra centrosomes do cause chromosome instability, Ganem and his colleagues have discovered, is by setting up a tug-of-war for chromosomes that are eventually caught between newly forming daughter cells of a dividing cancer cell. In normal cells, which have two centrosomes, division occurs as the pairs of chromosomes split neatly apart, like halves of a zipper, each set moving into one of the daughter cells. The extra centrosomes in cancer cells exert an unequal pull on some chromosomes, causing the daughter cells to inherit an irregular number of them - explaining, in part, why tumors are often filled with cells of varying quantities of chromosomes.

Their findings are reported in the journal Nature as an advanced online publication.

"Chromosome instability is a hallmark of most cancer cells, arising when chromosomes are missegregated into daughter cells during division," said Ganem, who led the study with senior author David Pellman, MD, and co-author Susana Godinho, PhD, of Dana-Farber. "Such instability may be a double-edged sword. It may confer a survival benefit on cancer cells by enabling them to adapt to a stressful environment in the body or by helping them become resistant to chemotherapy drugs. But it may also have deleterious effects that could make tumor cells susceptible to therapeutic attack."

"Although centrosome defects have been recognized in tumors for a long time," Pellman said, "it has been a tough problem to rigorously study. Neil and Susana have made a significant advance by developing useful methods to create comparable cells that carry or don't carry extra centrosomes."

In the early stages of division, cells make duplicate copies of their chromosomes, enabling their daughter cells to each receive an identical set. The centrosomes' role is to construct the mitotic spindle, the axis along which the chromosome pairs position themselves as division proceeds.

In normal cells, the two centrosomes serve as the polar ends of the spindle, the chromosomes arrayed between them like ranks of twin soldiers. Cells with more than two centrosomes enter a "multipolar" phase with several axes along which division may take place. Under a microscope, such cells look briefly like a sliced pizza ready to be pulled into three or four pieces.

But cancer cells usually avoid this fate by clustering extra centrosomes in a rough line, allowing a single spindle to form and division to proceed somewhat normally. In a study last year, researchers from Pellman's lab used genome-wide approaches to discover how this clustering occurs. In the current study, the investigators found that when cancer cells with extra centrosomes enter "anaphase" - the stage of cell division when chromosomes move toward the poles of the spindle before being drawn into the new daughter cells - a few chromosomes lagged behind the others. As a result, some of those chromosomes became homeless - left out of the daughter cell they were destined for, and marooned in the other daughter cell, where they inhabit a kind of island outside the nucleus where the other chromosomes congregate.

"We showed that even though most cancer cells with extra centrosomes form a single mitotic spindle, they pass through a brief 'multipolar spindle' stage," Ganem said. "The presence of this unique spindle configuration causes a few chromosomes to attach improperly to the eventual two-ended spindle. That, in turn, disrupts the normally orderly process by which chromosomes are pulled into the daughter cells."

According to Pellman, chromosomal instability, it turns out, "is actually a side effect of the cells' ability to cluster their excess centrosomes. From the standpoint of the tumor cell, it is a trade-off: the cell survives because it can correct for the surplus centrosomes, but the correction process creates other problems that result in chromosomal instability."

While the new study demonstrates that extra centrosomes are major actors - but likely not the only ones - in chromosome instability, it is an open question as to what causes some cells to have those extra centrosomes. That will be a future area of research for the Dana-Farber team.

Note: This story has been adapted from a news release issued by the Dana-Farber Cancer Institute

Post Comments:

Search

New Articles
New testing method hints at garlic's cancer-fighting potentialNew testing method hints at garlic's cancer-fighting potential

Targeting leukemia cell's gene 'addiction' presents new strategy for treatment

New biomarkers for predicting the spread of colon cancerNew biomarkers for predicting the spread of colon cancer

GenWay Biotech's You Test You puts early cancer detection tool in the hands of consumers

Gene-based stem cell therapy specifically removes cell receptor that attracts HIV

Notch-blocking drugs kill brain cancer stem cells, yet multiple therapies may be needed

Cells of aggressive leukemia hijack normal protein to growCells of aggressive leukemia hijack normal protein to grow

Bone marrow cell transplants to benefit those with heart disease

The sound of melanoma can help doctors find cancerThe sound of melanoma can help doctors find cancer

Bitter melon extract attacks breast cancer cellsBitter melon extract attacks breast cancer cells

Scanning for skin cancer: Infrared system looks for deadly melanomaScanning for skin cancer: Infrared system looks for deadly melanoma

What it might take to unravel the 'lean mean machine' that is cancer

Tumor mechanism identified

Melanoma transcriptome reveals novel genomic alterations not seen before

New DNA technique leads to a breakthrough in child cancer research



Archives
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
August 2006
June 2006
April 2006


Science Friends
Agricultural Science
Astronomy News
Biology News
Biomimicry Science
Cognitive Research
Chemistry News
Tissue Engineering
Cybernetics Research
Forensics Report
Fossil News
Genetic Archaeology
Genetics News
Geology News
Nanotech News
Physics News


  Archives |  Submit News |  Advertise With Us |  Contact Us |  Links
Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All contents © 2000 - 2011 Web Doodle, LLC. All rights reserved.
Web Doodle, LLC does not provide medical advice, diagnosis or treatment. Please read our disclaimer